Weight-adjusted low molecular weight heparin with surgery morning dose administration: Impact on hip hemiarthroplasty early infections

Key Points

• No significant change in early prosthetic joint infection (PJI) rates was observed when using a weight-adjusted low molecular weight heparin (LMWH) regimen.
• The approach involved administering the morning dose of LMWH without withholding it on the surgery day.
• A multicenter study is suggested to strengthen the evidence surrounding the use of LMWH in this context.
• The findings could guide future protocols for administering anticoagulation during hip hemiarthroplasty.

Abstract